H&R GMBH & CO KGAA (2HRA.DE) Stock Fundamental Analysis
FRA:2HRA - DE000A2E4T77 - Common Stock
4.95 EUR
-0.01 (-0.2%)
Taking everything into account, 2HRA scores 3 out of 10 in our fundamental rating. 2HRA was compared to 65 industry peers in the Chemicals industry. While 2HRA is still in line with the averages on profitability rating, there are concerns on its financial health. 2HRA does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
In the past year 2HRA was profitable.
In the past year 2HRA had a positive cash flow from operations.
Of the past 5 years 2HRA 4 years were profitable.
2HRA had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
2HRA's Return On Assets of 1.09% is in line compared to the rest of the industry. 2HRA outperforms 49.23% of its industry peers.
The Return On Equity of 2HRA (2.60%) is comparable to the rest of the industry.
Looking at the Return On Invested Capital, with a value of 2.77%, 2HRA is in line with its industry, outperforming 49.23% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for 2HRA is below the industry average of 7.08%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.09% | ||
| ROE | 2.6% | ||
| ROIC | 2.77% |
ROA(3y)2.22%
ROA(5y)2.24%
ROE(3y)5.04%
ROE(5y)5.21%
ROIC(3y)4.21%
ROIC(5y)4.11%
1.3 Margins
Looking at the Profit Margin, with a value of 0.82%, 2HRA is in line with its industry, outperforming 50.77% of the companies in the same industry.
In the last couple of years the Profit Margin of 2HRA has declined.
Looking at the Operating Margin, with a value of 2.46%, 2HRA is in line with its industry, outperforming 41.54% of the companies in the same industry.
2HRA's Operating Margin has improved in the last couple of years.
2HRA has a worse Gross Margin (23.75%) than 64.62% of its industry peers.
2HRA's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 2.46% | ||
| PM (TTM) | 0.82% | ||
| GM | 23.75% |
OM growth 3Y-26.17%
OM growth 5Y25.85%
PM growth 3Y-42.71%
PM growth 5YN/A
GM growth 3Y-4.08%
GM growth 5Y2.14%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), 2HRA is destroying value.
Compared to 1 year ago, 2HRA has about the same amount of shares outstanding.
2HRA has about the same amout of shares outstanding than it did 5 years ago.
2HRA has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 2.20 indicates that 2HRA is not a great score, but indicates only limited risk for bankruptcy at the moment.
2HRA has a Altman-Z score of 2.20. This is comparable to the rest of the industry: 2HRA outperforms 50.77% of its industry peers.
A Debt/Equity ratio of 0.14 indicates that 2HRA is not too dependend on debt financing.
2HRA has a better Debt to Equity ratio (0.14) than 78.46% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.14 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 2.2 |
ROIC/WACC0.49
WACC5.66%
2.3 Liquidity
2HRA has a Current Ratio of 1.51. This is a normal value and indicates that 2HRA is financially healthy and should not expect problems in meeting its short term obligations.
2HRA has a Current ratio of 1.51. This is comparable to the rest of the industry: 2HRA outperforms 43.08% of its industry peers.
A Quick Ratio of 0.83 indicates that 2HRA may have some problems paying its short term obligations.
The Quick ratio of 2HRA (0.83) is worse than 69.23% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.51 | ||
| Quick Ratio | 0.83 |
3. Growth
3.1 Past
2HRA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -16.15%.
2HRA shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -40.40% yearly.
2HRA shows a small growth in Revenue. In the last year, the Revenue has grown by 0.52%.
Measured over the past years, 2HRA shows a small growth in Revenue. The Revenue has been growing by 4.47% on average per year.
EPS 1Y (TTM)-16.15%
EPS 3Y-40.4%
EPS 5YN/A
EPS Q2Q%25%
Revenue 1Y (TTM)0.52%
Revenue growth 3Y4.04%
Revenue growth 5Y4.47%
Sales Q2Q%2.64%
3.2 Future
2HRA is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 4.74% yearly.
Based on estimates for the next years, 2HRA will show a small growth in Revenue. The Revenue will grow by 0.65% on average per year.
EPS Next Y-17.02%
EPS Next 2Y-3.24%
EPS Next 3Y4.74%
EPS Next 5YN/A
Revenue Next Year-3.15%
Revenue Next 2Y-0.22%
Revenue Next 3Y0.65%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 17.07 indicates a rather expensive valuation of 2HRA.
Compared to the rest of the industry, the Price/Earnings ratio of 2HRA indicates a somewhat cheap valuation: 2HRA is cheaper than 72.31% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 27.07. 2HRA is valued slightly cheaper when compared to this.
The Price/Forward Earnings ratio is 22.06, which indicates a rather expensive current valuation of 2HRA.
The rest of the industry has a similar Price/Forward Earnings ratio as 2HRA.
The average S&P500 Price/Forward Earnings ratio is at 22.59. 2HRA is around the same levels.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.07 | ||
| Fwd PE | 22.06 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of 2HRA indicates a rather cheap valuation: 2HRA is cheaper than 100.00% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 2.84 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-3.24%
EPS Next 3Y4.74%
5. Dividend
5.1 Amount
2HRA has a Yearly Dividend Yield of 2.02%. Purely for dividend investing, there may be better candidates out there.
2HRA's Dividend Yield is comparable with the industry average which is at 3.00.
Compared to an average S&P500 Dividend Yield of 2.46, 2HRA has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.02% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years2
5.3 Sustainability
2HRA pays out 33.69% of its income as dividend. This is a sustainable payout ratio.
DP33.69%
EPS Next 2Y-3.24%
EPS Next 3Y4.74%
FRA:2HRA (9/9/2025, 7:00:00 PM)
4.95
-0.01 (-0.2%)
Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)
Earnings (Next)
Inst Owners1.22%
Inst Owner ChangeN/A
Ins Owners6.06%
Ins Owner ChangeN/A
Market Cap184.24M
Analysts43.64
Price Target5.1 (3.03%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.02% |
Yearly Dividend0.1
Dividend Growth(5Y)N/A
DP33.69%
Div Incr Years0
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.32%
PT rev (3m)-1.32%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-38.42%
EPS NY rev (3m)-38.42%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-5.36%
Revenue NY rev (3m)-2.36%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.07 | ||
| Fwd PE | 22.06 | ||
| P/S | 0.14 | ||
| P/FCF | N/A | ||
| P/OCF | 3.63 | ||
| P/B | 0.43 | ||
| P/tB | 0.47 | ||
| EV/EBITDA | 2.84 |
EPS(TTM)0.29
EY5.86%
EPS(NY)0.22
Fwd EY4.53%
FCF(TTM)-0.1
FCFYN/A
OCF(TTM)1.36
OCFY27.55%
SpS36.19
BVpS11.42
TBVpS10.61
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.09% | ||
| ROE | 2.6% | ||
| ROCE | 4.67% | ||
| ROIC | 2.77% | ||
| ROICexc | 3.07% | ||
| ROICexgc | 3.22% | ||
| OM | 2.46% | ||
| PM (TTM) | 0.82% | ||
| GM | 23.75% | ||
| FCFM | N/A |
ROA(3y)2.22%
ROA(5y)2.24%
ROE(3y)5.04%
ROE(5y)5.21%
ROIC(3y)4.21%
ROIC(5y)4.11%
ROICexc(3y)4.64%
ROICexc(5y)4.53%
ROICexgc(3y)4.9%
ROICexgc(5y)4.79%
ROCE(3y)7.11%
ROCE(5y)6.95%
ROICexcg growth 3Y-25.59%
ROICexcg growth 5Y22.95%
ROICexc growth 3Y-25.37%
ROICexc growth 5Y23.82%
OM growth 3Y-26.17%
OM growth 5Y25.85%
PM growth 3Y-42.71%
PM growth 5YN/A
GM growth 3Y-4.08%
GM growth 5Y2.14%
F-Score5
Asset Turnover1.33
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.14 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 0.62 | ||
| Cap/Depr | 86.79% | ||
| Cap/Sales | 4.06% | ||
| Interest Coverage | 3.77 | ||
| Cash Conversion | 52.82% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.51 | ||
| Quick Ratio | 0.83 | ||
| Altman-Z | 2.2 |
F-Score5
WACC5.66%
ROIC/WACC0.49
Cap/Depr(3y)102.18%
Cap/Depr(5y)93.34%
Cap/Sales(3y)4.27%
Cap/Sales(5y)4.26%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-16.15%
EPS 3Y-40.4%
EPS 5YN/A
EPS Q2Q%25%
EPS Next Y-17.02%
EPS Next 2Y-3.24%
EPS Next 3Y4.74%
EPS Next 5YN/A
Revenue 1Y (TTM)0.52%
Revenue growth 3Y4.04%
Revenue growth 5Y4.47%
Sales Q2Q%2.64%
Revenue Next Year-3.15%
Revenue Next 2Y-0.22%
Revenue Next 3Y0.65%
Revenue Next 5YN/A
EBIT growth 1Y-10.57%
EBIT growth 3Y-23.19%
EBIT growth 5Y31.47%
EBIT Next Year199.94%
EBIT Next 3Y49.9%
EBIT Next 5YN/A
FCF growth 1Y-121.54%
FCF growth 3YN/A
FCF growth 5Y-5.95%
OCF growth 1Y-44.36%
OCF growth 3Y23.36%
OCF growth 5Y-6.03%